Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 trial evaluating intravenous efgartigimod versus placebo in adults with primary Sjögren’s syndrome. It provides the study’s design, eligibility criteria, participating locations, and primary and secondary outcome measures.
    Difference
    53%
    Check dated 2026-11-09T13:42:33.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:58:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T14:10:44.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the study record continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:26.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-10-12T14:43:59.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the detailed study content with an error page. As a result, the trial's title, conditions, locations, documents, and other structured data become inaccessible in this view.
    Difference
    18%
    Check dated 2026-09-21T21:57:15.000Z thumbnail image

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.